Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer.
Carola C, Ghiringhelli F, Kim S, André T, Barlet J, Bengrine-Lefevre L, Marijon H, Garcia-Larnicol ML, Borg C, Dainese L, Steuer N, Richa H, Benetkiewicz M, Larsen AK, de Gramont A, Chibaudel B. Carola C, et al. World J Clin Oncol. 2018 Sep 14;9(5):110-118. doi: 10.5306/wjco.v9.i5.110. World J Clin Oncol. 2018. PMID: 30254966 Free PMC article.
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study.
Bidard FC, Tournigand C, André T, Mabro M, Figer A, Cervantes A, Lledo G, Bengrine-Lefevre L, Maindrault-Goebel F, Louvet C, de Gramont A. Bidard FC, et al. Ann Oncol. 2009 Jun;20(6):1042-7. doi: 10.1093/annonc/mdn730. Epub 2009 Jan 19. Ann Oncol. 2009. PMID: 19153116 Free article. Clinical Trial.
[Management of metastatic colorectal cancer].
Tournigand C, Bengrine-Lefevre L, Chibaudel B, de Gramont A. Tournigand C, et al. Rev Prat. 2010 Oct 20;60(8):1103-7. Rev Prat. 2010. PMID: 21197743 French.
[Nasal septum perforation and bevacizumab].
Bengrine-Lefevre L, Afchain P, Chibaudel B, Gervais H, Tournigand C, De Gramont A, Louvet C. Bengrine-Lefevre L, et al. Rev Med Interne. 2011 Apr;32(4):e43-5. doi: 10.1016/j.revmed.2010.04.015. Epub 2010 Jun 17. Rev Med Interne. 2011. PMID: 21470582 French.
Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.
Chibaudel B, Bonnetain F, Tournigand C, Bengrine-Lefevre L, Teixeira L, Artru P, Desramé J, Larsen AK, André T, Louvet C, de Gramont A. Chibaudel B, et al. Oncologist. 2011;16(9):1228-38. doi: 10.1634/theoncologist.2011-0039. Epub 2011 Aug 22. Oncologist. 2011. PMID: 21859820 Free PMC article. Clinical Trial.
Platinum-sensitivity in metastatic colorectal cancer: towards a definition.
Chibaudel B, Tournigand C, Bonnetain F, Maindrault-Goebel F, Lledo G, André T, Larsen AK, Bengrine-Lefevre L, Louvet C, de Gramont A. Chibaudel B, et al. Eur J Cancer. 2013 Dec;49(18):3813-20. doi: 10.1016/j.ejca.2013.07.150. Epub 2013 Sep 3. Eur J Cancer. 2013. PMID: 24011937
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen.
Limagne E, Euvrard R, Thibaudin M, Rébé C, Derangère V, Chevriaux A, Boidot R, Végran F, Bonnefoy N, Vincent J, Bengrine-Lefevre L, Ladoire S, Delmas D, Apetoh L, Ghiringhelli F. Limagne E, et al. Cancer Res. 2016 Sep 15;76(18):5241-52. doi: 10.1158/0008-5472.CAN-15-3164. Epub 2016 Aug 5. Cancer Res. 2016. PMID: 27496709 Clinical Trial.
53 results